Vet Pharma Friesoythe GmbH – FDA 483, Mar 24, 2023
Vet Pharma Friesoythe GmbH was cited for significant deficiencies in aseptic processing, quality control, and complaint handling during an FDA inspection. Observations included poor aseptic techniques, inadequate environmental monitoring, insufficient cleaning procedures, and a failure to thoroughly investigate product defects like leaking bottles and particulate contamination. The report highlights repeat observations from previous inspections, indicating persistent issues with manufacturing controls and quality systems.
ID · b6e21207-217c-461c-aa01-4d3818d9852e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.